Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome.

BACKGROUND Inflammatory cytokines (ICs) are important modulators of injury and repair. ICs have been found to be elevated in the BAL of patients with both early and late ARDS. We tested the hypothesis that recurrent injury to the alveolocapillary barrier and amplification of intra-alveolar fibroproliferation observed in nonresolving ARDS is related to a persistent inflammatory response. For this purpose, we obtained serial measurements of BAL IC and correlated these levels with lung injury score (LIS), BAL indexes of endothelial permeability (albumin, total protein [TP]), and outcome. METHODS We prospectively studied 27 consecutive patients with severe medical ARDS. Using enzyme-linked immunosorbent assay methods, levels of tumor necrosis factor-alpha (TNF-alpha) and interleukins (IL) 1 beta, 2, 4, 6, and 8 were measured at frequent intervals in both plasma and BAL. In 22 patients, bilateral BAL was obtained on day 1 of ARDS and at weekly intervals when possible. Right and left BALs were analyzed separately for IC levels, total cell count and differential, albumin, TP, and quantitative bacterial cultures. RESULTS On day 1 of ARDS, the 10 nonsurvivors had significantly higher (p = 0.0002) BAL TNF-alpha, IL-1 beta, IL-6, and IL-8 levels, which remained persistently elevated over time, indicating a continuous injury process. In contrast, the 12 survivors had a lesser elevation and a rapid reduction over time. Initial BAL IL-2 and IL-4 levels were significantly higher in patients with sepsis (p = 0.006); both increased over time in survivors and nonsurvivors. BAL levels of TNF-alpha, IL-1 beta, IL-6, and IL-8 correlated with BAL albumin and TP concentrations but not with LIS or ratio of arterial oxygen tension to inspired oxygen concentration. BAL: plasma ratios were elevated for all measured cytokines, suggesting a pulmonary origin. On day 1 of ARDS, nonsurvivors had significantly higher (p = 0.04) BAL: plasma ratios for TNF-alpha, IL-1 beta, IL-6, and IL-8. Over time, BAL:plasma ratios for TNF-alpha, IL-1 beta and IL-6 remained elevated in nonsurvivors and decreased in survivors. CONCLUSIONS Our findings indicate that an unfavorable outcome in ARDS is associated with an initial, exaggerated, pulmonary inflammatory response that persists unabated over time. Plasma IC levels parallel changes in BAL IC levels. The BAL:plasma ratio results suggest, but do not prove, a pulmonary origin for IC production. BAL TNF-alpha, IL-1 beta, and IL-8 levels correlated with BAL indices of endothelial permeability. In survivors, reduction in BAL IC levels over time was associated with a decline in BAL albumin and TP levels, suggesting effective repair of the endothelial surface. These findings support a causal relationship between degree and duration of lung inflammation and progression of fibroproliferation in ARDS.

[1]  J F Murray,et al.  An expanded definition of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[2]  W. Shoemaker,et al.  Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury. , 1994, The Journal of trauma.

[3]  J. Heffner,et al.  Clinical predictors of prolonged translaryngeal intubation in patients with the adult respiratory distress syndrome. , 1990, Chest.

[4]  J. Murray,et al.  Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. , 1990, The American review of respiratory disease.

[5]  P. Dorinsky,et al.  Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. , 1986, The American review of respiratory disease.

[6]  P Franchimont,et al.  Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.

[7]  M. Chiaranda,et al.  Levels of interleukin-8 in patients with adult respiratory distress syndrome. , 1993, The Journal of infectious diseases.

[8]  R. Sauerwein,et al.  Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.

[9]  G. Campbell,et al.  Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. , 1989, The American review of respiratory disease.

[10]  M. Singer,et al.  TUMOUR NECROSIS FACTOR IN BRONCHOPULMONARY SECRETIONS OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME , 1989, The Lancet.

[11]  C. Henke,et al.  Fibroproliferative disorders. , 1991, Chest.

[12]  J. Carlet,et al.  Expression of Tumor Necrosis Factor-α Gene in Alveolar Macrophages from Patients with the Adult Respiratory Distress Syndrome , 1993 .

[13]  J. Rosenbloom,et al.  Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.

[14]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[15]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[16]  T. Calandra,et al.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. , 1991, The American journal of medicine.

[17]  P. Montravers,et al.  Relationships between Polymorphonuclear Neutrophils and Cytokines in Patients with Adult Respiratory Distress Syndrome , 1994, Annals of the New York Academy of Sciences.

[18]  F. Shofer,et al.  Plasma cytokine determinations in emergency department patients as a predictor of bacteremi and infectious disease severity , 1994, Critical care medicine.

[19]  R. Hamman,et al.  Adult respiratory distress syndrome. Prognosis after onset. , 1985, The American review of respiratory disease.

[20]  A. Fowler,et al.  Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. , 1989, Experimental lung research.

[21]  J. Cavaillon,et al.  Circulating interleukin‐8 concentrations in patients with multiple organ failure of septic and nonseptic origin , 1994, Critical care medicine.

[22]  J. Vincent,et al.  Influence of an anti‐tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis , 1993, Critical care medicine.

[23]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[24]  M. Matthay,et al.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. , 1992, The American review of respiratory disease.

[25]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[26]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[27]  R. Strieter,et al.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.

[28]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[29]  F. Stentz,et al.  Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. , 1995, Chest.

[30]  E. Girardin,et al.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. , 1988, The New England journal of medicine.

[31]  L. Bossaert,et al.  Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. , 1992, Cytokine.

[32]  A. Burkhardt,et al.  Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. , 1989, The American review of respiratory disease.

[33]  P. Minoo,et al.  Regulation of lung cell proliferation by polypeptide growth factors. , 1989, The American journal of physiology.

[34]  J. Vincent,et al.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.

[35]  C. Sprung,et al.  High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.

[36]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[37]  P. Bitterman.  Pathogenesis of fibrosis in acute lung injury. , 1992, The American journal of medicine.

[38]  E. Draper,et al.  Prognosis in Acute Organ‐System Failure , 1985, Annals of surgery.

[39]  J. Seyer,et al.  Stimulation of fibroblast chemotaxis by human recombinant tumor necrosis factor alpha (TNF-alpha) and a synthetic TNF-alpha 31-68 peptide , 1990, The Journal of experimental medicine.

[40]  J. Seyer,et al.  Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. , 1991, The Journal of clinical investigation.

[41]  P. Montravers,et al.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome , 1993, Infection and immunity.

[42]  S. Mostafa,et al.  TUMOUR NECROSIS FACTOR AND ADULT RESPIRATORY DISTRESS SYNDROME , 1989, The Lancet.

[43]  A. Ishizaka,et al.  Serum concentration of 7S collagen and prognosis in patients with the adult respiratory distress syndrome. , 1994, Thorax.

[44]  E. Weibel,et al.  Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. , 2015, The American review of respiratory disease.

[45]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .

[46]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[47]  M. Antonelli,et al.  Tumor necrosis factor in serum and in bronchoalveolar lavage of patients at risk for the adult respiratory distress syndrome , 1992 .

[48]  T. Evans,et al.  Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. , 1994, Chest.

[49]  P. Barie,et al.  Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. , 1990, Surgery, gynecology & obstetrics.

[50]  R. Bone,et al.  The pathogenesis of sepsis. , 1991, Annals of internal medicine.

[51]  J. Schellekens,et al.  Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock , 1990 .

[52]  E. Kovacs,et al.  Fibrogenic cytokines and connective tissue production , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  C. Mason,et al.  Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. , 1994, American journal of respiratory and critical care medicine.

[54]  M. Jordana,et al.  Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. , 1994, American journal of respiratory cell and molecular biology.

[55]  H. Winer-Muram,et al.  Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. , 1994, Chest.

[56]  C. Sprung,et al.  Lung microvascular transport properties measured by multiple indicator dilution methods in patients with adult respiratory distress syndrome. A comparison between patients reversing respiratory failure and those failing to reverse. , 1990, The American review of respiratory disease.

[57]  J. Chastre,et al.  The Standardization of Bronchoscopic Techniques for Ventilator-Associated Pneumonia , 1992, Infection Control & Hospital Epidemiology.

[58]  S. Suter,et al.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. , 1992, The American review of respiratory disease.

[59]  A. Fowler,et al.  Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. , 1991, The American review of respiratory disease.

[60]  M. Lamy,et al.  Pathologic features and mechanisms of hypoxemia in adult respiratory distress syndrome. , 1976, The American review of respiratory disease.

[61]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[62]  R. Wunderink,et al.  Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. , 1994, Chest.

[63]  R. Wunderink,et al.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. , 1991, Chest.

[64]  F. Stentz,et al.  Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. , 1995, Chest.

[65]  J. Grassi,et al.  Production of monoclonal antibodies against interleukin-1α and -1β: Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media , 1989 .